Innate Pharma SA Deferred Tax Liabilities
Innate Pharma SA (IPHA) had Deferred Tax Liabilities of EUR 9.12 million as of 2024-06-30, per its 6-K filed 2024-09-12.
Discontinued › Notes › Income Taxes
ifrs-full:DeferredTaxLiabilities · last filed 2024-09-12
- 2024-06-30: Deferred Tax Liabilities 9.12M EUR.
- 2023-12-31: Deferred Tax Liabilities 9.01M EUR.
- 2023-06-30: Deferred Tax Liabilities 9.67M EUR.
- 2022-12-31: Deferred Tax Liabilities 8.57M EUR.
| Period end | Deferred Tax Liabilities |
|---|---|
| 2024-06-30 | 9.12M EUR 6-K · filed 2024-09-12 |
| 2023-12-31 | 9.01M EUR 6-K · filed 2024-09-12 |
| 2023-06-30 | 9.67M EUR 6-K · filed 2023-09-14 |
| 2022-12-31 | 8.57M EUR 20-F · filed 2024-04-04 |
| 2022-06-30 | 7.78M EUR 6-K · filed 2022-09-15 |
| 2021-12-31 | 5.03M EUR 20-F · filed 2024-04-04 |
| 2021-06-30 | 5.40M EUR 6-K · filed 2021-09-15 |
| 2020-12-31 | 7.09M EUR 20-F · filed 2023-04-06 |
| 2019-12-31 | 1.29M EUR 20-F · filed 2022-04-04 |
| 2018-12-31 | 1.56M EUR 20-F · filed 2021-04-27 |